When Arcutis Biotherapeutics set out to build a community around seborrheic dermatitis, or seb derm, the first challenge was getting the members of that community to recognize that there was a disease ...

Add Yahoo as a preferred source to see more of our stories on Google. It’s been said before and it’s true: a healthy scalp is key to healthy hair. But for those dealing with pesky and sometimes ...

This article was reviewed by Knox Beasley, MD. Flakes on your scalp making you feel self-conscious? Let's talk about seborrheic dermatitis vs dandruff. Whether your scalp feels like a snowglobe thanks ...

Seborrheic dermatitis is positively associated with a range of epithelial barrier diseases, including dermatologic, respiratory, gastrointestinal, and ocular diseases. Seborrheic dermatitis is ...

While "seborrheic dermatitis" (seb derm) may not be a household name, one of its most common visible symptoms—flakes that may be mistaken as dandruff—is very familiar. What you may not know is that ...

Arcutis Biotherapeutics launched a campaign Monday focused on seborrheic dermatitis, highlighting personal journeys from patients with the disease as well as tips from dermatologists. The Clearing Up ...

Researchers at the Perelman School of Medicine at the University of Pennsylvania report that adults with seborrheic dermatitis in a large US cohort had higher odds of multiple epithelial barrier ...

Regions with cold weather and during winter months are known for causing negative effects on our scalps, which are typically displayed as dryness, irritation, and flakiness. So when you see flakes, ...

Credit: Arcutis. Zoryve topical foam is a once-daily steroid-free formulation of a highly potent and selective phosphodiesterase type 4 inhibitor. The Food and Drug Administration (FDA) has approved ...

Seborrheic dermatitis (SD) is a common, chronic, relapsing, inflammatory skin disorder clinically characterized by ill-defined, flaky, white to yellowish scales, with or without reddened skin. It ...

Researchers conducted a meta-analysis of 121 studies, which included 1,260,163 people with clinician-diagnosed seborrheic dermatitis. The included studies represented nine countries; most were from ...